2018 American Transplant Congress Archives - Page 32 of 211

CMV Viremia and Development of CMV-Specific Cytotoxic T-Cells (CMV-Tc) in Pediatric Renal Transplant Recipients

H. Pizzo, B. Shin, M. Toyoda, S. Jordan, D. Puliyanda.
CMV-Specific CD8+ T-Cell Immune Competence Score as Predictor of Outcome for CMV Infection after Transplantation

A. Meesing,¹ R. Abraham,² R. Razonable.¹
CMV-Specific Cell-Mediated Immunity after Valgancyclovir Prophylaxis Predicts Late Onset CMV Infection in Kidney Transplant Patients

M. Jarque,¹ E. Crespo,¹ E. Melilli,² A. Manonelles,² N. Montero,² S. Luque,¹ J. Cruzado,^1,2 J. Grinyo,^1,2 O. Bestard.^1,2
Cognition after Belatacept Conversion

C. Ogbejesi, E. Cohen, K. Belfield, W. Asch.
Cognition and Self-Management in Liver Transplant Recipients

D. Ko,¹ L. Bratzke,² R. Muehrer.²
Cognitive Function and Health Literacy Assessment Outcomes in the First Months after Renal Transplant in a Diverse Single Center Population

J. Trofe-Clark,^1,2 W. Gbemudu,¹ S. Hamel,¹ J. Shults,¹ R. Neubauer,² S. Ryan,¹ M. Kaminski,¹ D. Sawinski,² S. Goral,² M. Bleicher,² M. Lim,² R. Bloom,² P. Reese.²
Cognitive Impairment and Graft Loss in Kidney Transplant Recipients

A. Thomas,¹ J. Ruck,¹ A. Shaffer,¹ C. Haugen,¹ H. Ying,¹ F. Warsame,¹ N. Chu,¹ M. Carlson,¹ A. Gross,¹ S. Norman,² D. Segev,¹ M. McAdams-DeMarco.¹
Cognitive Impairment Influences Transplant Eligibility

A. Gupta, J. Klein, J. Mahnken, R. Montgomery, A. Ilahe, P. Budhiraja, T. Thomas, T. Schmitt, J. Burns, D. Cibrik.
Cold Ischemia Time is an Important Risk Factor for Post-Liver Transplant Prolonged Length of Stay

E. Pan, D. Yoeli, N. Galvan, M. Kueht, R. Cotton, C. O'Mahony, J. Goss, A. Rana.
Cold Pulsatile Machine Perfusion versus Static Cold Storage in Kidneys from Donation after Circulatory Death: A Multi-Centre Randomised Controlled Trial

D. Summers,^1,2 L. Randle,¹ A-.M. O'Sullivan,³ R. Johnson,² D. Collett,² M. Attia,⁴ N. Ahmad,⁴ M. Clancy,⁵ M. Akyol,⁶ A. Tavakoli,⁷ N. Jamieson,³ A. Bradley,¹ C. Watson.¹